NCT03161223
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University of Virginia Charlottesville, Virginia, United States
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
181 public trials
52 recruiting studies
Lymphoma, T-Cell trial results
NCT03869619
- Conditions
- Burkitt Lymphoma, Burkitt Lymphoma (BL)), DNA Virus Infections, +26 more
- Locations
-
- Unité d'Hématologie Clinique, CH D'ARRAS Arras, France
- Service d'Hématologie, CHU Jean Minjoz Besançon, France
- Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
- Institut Bergonié Bordeaux, France
Enrolling by Invitation
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
NCT03628612
- Conditions
- ALL, Adult and Pediatric, Blood Protein Disorders, Cardiovascular Diseases, +20 more
- Locations
-
- University of Miami Miami, Florida, United States
- Washington University in St. Louis St Louis, Missouri, United States
- St David's South Austin Medical Center Austin, Texas, United States
- Queen Elizabeth University Hospital Glasgow, United Kingdom
Not Yet Recruiting
Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma
NCT07691450
- Conditions
- Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +36 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Not Yet Recruiting
A Multi-center, Prospective, Registry Study to Analyze the Clinical Characteristics and Prognosis of Different Molecular Subtypes of Peripheral T-cell Lymphoma.
NCT07657572
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
Not specified
Not Yet Recruiting
Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.
NCT07538960
- Conditions
- Cutaneous, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Hospital México San José, Uruca, Costa Rica
Not Yet Recruiting
EZH2 Inhibitor Zeprumetostat in Combination Therapy for Patients With Relapsed or Refractory Mature T-cell and NK-cell Lymphomas
NCT07339527
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
Not specified
Not Yet Recruiting
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation
NCT07117305
- Conditions
- CD7+ Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University, Department of Oncology Zhengzhou, Henan, China
NCT03259503
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03703375
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Local Institution - 41822 Sapporo, Hokkaido, Japan
- Local Institution - 41922 Okayama, Okayama-ken, Japan
- Local Institution - 41722 Sayama, Osaka, Japan
- Local Institution - 41422 Hidaka, Saitama-Pref, Japan